Abstract
Objective
The objective of the present study was to develop a fully automated blood sampling system for kinetic analysis in mice positron emission tomography (PET) studies. Quantitative PET imaging requires radioactivity concentrations in arterial plasma to estimate the behavior of an administered radiopharmaceutical in target organs. Conventional manual blood sampling has several drawbacks, such as the need for troubleshooting in regard to blood collection, necessary personnel, and the radiation exposure dose. We recently developed and verified the operability of a fully automated blood sampling system (automatic blood dispensing system—ABDS). Here, we report the results of fully quantitative measurements of the cerebral metabolic rate of glucose (CMRglc) in mice using the ABDS.
Methods
Under 1% isoflurane anesthesia, a catheter was inserted into the femoral artery of nine wild-type male mice. Immediately after injection of 18F-fluorodeoxyglucose (FDG) (13.2 ± 3.93 MBq in 0.1 mL saline), arterial blood samples were drawn using the ABDS and then analyzed using CD-Well, a system we previously developed that can measure radioactivity concentration (Bq/μL) using a few microliters of blood in the plasma and whole blood separately. In total, 16 blood samplings were conducted in 60 min as follows: 10 s × 9; 70 s × 2; 120 s × 1; 250 s × 1; 10 min × 2; and 30 min × 1. Dynamic PET scans were conducted concurrently using a small-animal PET/computed tomography (CT) (PET/CT) scanner. Full kinetics modeling using a two-tissue–three-compartment model was applied to calculate CMRglc. Blood volume was also estimated.
Results
No significant differences were observed between the manual and ABDS measurements. A proportional error was detected only for plasma. The mean ± standard deviation CMRglc value in the mice was 5.43 ± 1.98 mg/100 g/min (30.2 ± 11 μmol/min/100 g), consistent with a previous report.
Conclusions
The automated microliter-ordered blood sampling system developed in the present study appears to be useful for absolute quantification of CMRglc in mice PET studies.
Similar content being viewed by others
References
Wagner HN Jr. Molecular imaging: thriving all over the world. J Nucl Med. 2007;48(8):15N-16N, 19N-38N.
Toyama H. Issues of quantitative metabolic brain imaging with small animal PET in mice. Curr Med Imaging Rev. 2005;1(3):245–51.
Hume SP, Myers R. Dedicated small animal scanners: a new tool for drug development? Curr Pharm Des. 2002;8(16):1497–511.
Toyama H, Ye D, Ichise M, Liow JS, Cai L, Jacobowitz D, et al. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2005;32(5):593–600.
Watabe H, Ikoma Y, Kimura Y, Naganawa M, Shidahara M. PET kinetic analysis–compartmental model. Ann Nucl Med. 2006;20(9):583–8.
Wu HM, Sui G, Lee CC, Prins ML, Ladno W, Lin HD, et al. In vivo quantitation of glucose metabolism in mice using small-animal PET and a microfluidic device. J Nucl Med. 2007;48(5):837–45.
Convert L, Morin-Brassard G, Cadorette J, Archambault M, Bentourkia M, Lecomte R. A new tool for molecular imaging: the microvolumetric beta blood counter. J Nucl Med. 2007;48(7):1197–206.
Pain F, Laniece P, Mastrippolito R, Gervais P, Hantraye P, Besret L. Arterial input function measurement without blood sampling using a beta-microprobe in rats. J Nucl Med. 2004;45(9):1577–82.
Maramraju S, Stoll S, Woody C, Schlyer D, Schiffer W, Lee D, et al. A LSO β microprobe for measuring input functions for quantitative small animal PET. Nucl Instrum Methods Phys Res. 2007;571(1):407–10.
Kimura Y, Seki C, Hashizume N, Yamada T, Wakizaka H, Nishimoto T, et al. Novel system using microliter order sample volume for measuring arterial radioactivity concentrations in whole blood and plasma for mouse PET dynamic study. Phys Med Biol. 2013;58(22):7889–903.
Rao S, Verkman AS. Analysis of organ physiology in transgenic mice. Am J Physiol Cell Physiol. 2000;279(1):C1–18.
Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-glucose: validation of method. Ann Neurol. 1979;6(5):371–88.
Ackermann RF, Lear JL. Glycolysis-induced discordance between glucose metabolic rates measured with radiolabeled fluorodeoxyglucose and glucose. J Cereb Blood Flow Metab. 1989;9(6):774–85.
Toyama H, Ichise M, Liow JS, Modell KJ, Vines DC, Esaki T, et al. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography. J Nucl Med. 2004;45(8):1398–405.
Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28(5):897–916.
Esaki T, Cook M, Shimoji K, Murphy DL, Sokoloff L, Holmes A. Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proc Natl Acad Sci USA. 2005;102(15):5582–7.
Esaki T, Suzuki H, Cook M, Shimoji K, Cheng SY, Sokoloff L, et al. Functional activation of cerebral metabolism in mice with mutated thyroid hormone nuclear receptors. Endocrinology. 2003;144(9):4117–22.
Acknowledgements
This work was supported by JSPS Grant-in-Aid for Young Scientists (B) Grant Number JP15K19823 in 2015–2018.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Takenaka, A., Inui, Y., Kimura, Y. et al. Microliter-ordered automatic blood sampling system for fully quantitative analysis of small-animal PET. Ann Nucl Med 33, 586–593 (2019). https://doi.org/10.1007/s12149-019-01368-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-019-01368-3